Eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Clin Adv Hematol Oncol. 2005 Nov;3(11):849-50.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials, Phase III as Topic
  • Complement C5 / antagonists & inhibitors
  • Hemoglobinuria, Paroxysmal / drug therapy*
  • Humans
  • Pilot Projects
  • Predictive Value of Tests
  • Thrombosis / prevention & control
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Complement C5
  • eculizumab